GlassScriptPhysician profile
Beverly A Spurs
NPI 1710045620
$3,927.64
in general payments reported to CMS, 2019-2025
21 companies · $567 in 2025
The $567 reported for 2025 was more than what 75% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $322 · 2021: $342 · 2022: $801 · 2023: $609 · 2024: $687 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,697.48 | 2019-2025 | Collagenase Santyl, Pico, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Bioventus LLC | $527.99 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $441.34 | 2019-2024 | Nushield, Puraply Wound Matrix, Apligraf |
| Kerecis Limited | $262.40 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Convatec INC. | $162.56 | 2023-2025 | |
| Polarityte, INC. | $133.61 | 2019-2021 | |
| Stryker Corporation | $132.83 | 2022-2024 | Augment Injectable, 7 X 23mm Citrelock Implant |
| Musculoskeletal Transplant Foundation INC. | $123.63 | 2020-2022 | |
| Crossroads Extremity Systems, LLC | $92.05 | 2019 | |
| Nevro Corp. | $63.95 | 2022 | |
| Tactile Systems Technology INC | $37.63 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Arthrosurface Incorporated | $37.50 | 2019 | |
| Orthofix Medical, INC. | $32.57 | 2023 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $30.64 | 2020 | |
| Grt US Holding, INC. | $27.72 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $25.57 | 2025 | Promogran Prisma, 3m Cavilon, Activ.A.C. |
| Fidia Pharma USA INC. | $24.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.69 | 2022 | |
| Integra Lifesciences Corporation | $19.91 | 2022 | |
| Nabriva Therapeutics, Plc | $18.62 | 2022 | |
| Medela LLC | $14.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Spurs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.